LGND Related
-
Form 4 LIGAND PHARMACEUTICALS For: Jun 11 Filed by: Sabba Stephen L
-
Form 4 LIGAND PHARMACEUTICALS For: Jun 11 Filed by: KNOTT DAVID M
-
Form 4 LIGAND PHARMACEUTICALS For: Jun 11 Filed by: Patel Sunil
-
Form 4 LIGAND PHARMACEUTICALS For: Jun 11 Filed by: LAMATTINA JOHN L
-
Form 4 LIGAND PHARMACEUTICALS For: Jun 11 Filed by: KOZARICH JOHN W
-
Form 4 LIGAND PHARMACEUTICALS For: Jun 11 Filed by: Davis Todd C
-
Form 4 LIGAND PHARMACEUTICALS For: Jun 11 Filed by: Aryeh Jason
-
Form 8-K LIGAND PHARMACEUTICALS For: Jun 11
-
Form 4 LIGAND PHARMACEUTICALS For: Jun 03 Filed by: HIGGINS JOHN L
-
Form 4 LIGAND PHARMACEUTICALS For: Jun 03 Filed by: FOEHR MATTHEW W
-
Form 8-K LIGAND PHARMACEUTICALS For: Jun 03
-
Ligand Provides New Corporate Presentation at Investor Conference
-
Ligand to Present at Upcoming Investor Conferences
-
Ligand Pharmaceuticals (LGND) Agreement with Merck KGaA Unit Terminated
-
Form 8-K LIGAND PHARMACEUTICALS For: May 17
-
Ligand Partner Rib-X Initiates Phase 3 Trial of Captisol-enabled™ Delafloxacin IV
-
Form 4 LIGAND PHARMACEUTICALS For: May 10 Filed by: Berkman Charles S
-
Ligand Pharmaceuticals, Inc. (LGND) Tops Q1 EPS by 7c; Approves $5M Buyback
-
Form 10-Q LIGAND PHARMACEUTICALS For: Mar 31
-
Form 8-K LIGAND PHARMACEUTICALS For: May 08
-
Ligand Reports First Quarter Financial Results
-
Form 8-K LIGAND PHARMACEUTICALS For: Apr 29
-
Ligand Acquires Financial Rights to More Than 15 Fully-Funded Development Programs from Selexis SA
-
Ligand Presents Preclinical Data on HepDirect™ Liver-Targeting Technology Platform at 2013 International Liver Congress (EASL) Annual Meeting
-
Ligand to Present at Upcoming Investor Conferences
-
Ligand to Report First Quarter Results on May 8th
-
Ligand Pharmaceuticals, Inc. (LGND) Reports Q4 EPS of $0.19
-
Cantor Fitzgerald Downgrades Ligand Pharma (LGND) to Hold
-
FDA Accepts Pfizer (PFE) Ligand (LGND) NDA For Bazedoxifene/Conjugated Estrogens
-
Ligand Pharma (LGND) Issues FY13 Outlook into Analyst Day
-
Unusual 11 Mid-Day Movers 11/19: (BMTI) (CAK) (UTSI) Higher; (TSTC) (LRN) (DMND) Lower
-
Ligand Pharma (LGND) shares resume trading; shares up ~8%
-
Ligand Pharma (LGND) to resume trading at 9:45AM after FDA approval
-
Ligand (LGND), Glaxo (GSK) Receive FDA Approval for PROMACTA in HCV Patients
-
Ligand Pharmaceuticals (LGND), GSK's (GSK) promacta approved - Report
-
Ligand Pharmaceuticals (LGND) halted, news pending
-
Ligand Pharmaceuticals, Inc. (LGND) Misses Q3 EPS by 5c
-
Ligand Pharma (LGND) to Restate FY11, Q112, Q212 Financials
-
Trading Radar for 11/05: Humana (HUM), Tesla Motors (TSLA), Zillow (Z), Express Scripts (ESRX), Time Warner Cable (TWC) Report
-
Ligand Pharmaceuticals (LGND) Announces $2M Milestone Payment, Affirms 2012 Revenue Guidance
-
Griffin Securities Reiterates a 'Buy' on Ligand Pharma (LGND); Investors Jumped The Gun...Attractive Opportunity
-
Ligand Pharmaceuticals, Inc. (LGND) Misses Q2 EPS by 18c
-
Trading Radar for 08/08: Macy's (M), Orbitz Worldwide (OWW), SodaStream (SODA), SunPower (SPWR), News Corp (NWSA) Report
-
Ligand (LGND) Partner GlaxoSmithKline (GSK) Granted Priority Review for Promacta
-
Cantor Fitzgerald Maintains a 'Buy' on Ligand Pharma (LGND); Key Partnered Drug is Approved
-
UPDATE: Onyx Pharmaceuticals (ONXX) Kyprolis approved
-
Roth Capital Starts Ligand Pharma (LGND) at Buy
-
Top 10 News Items 6/18-6/22: Fed Slams the Door on QE3 But Extends Operation Twist; Greek Elections Take Help Ease Pressure; Moody's Downgrades Banks Across the Board
-
Unusual 11 Mid-Day Movers 06/21: (ONXX) (SUNH) (EGLE) Higher; (BBBY) (POZN) (KEG) Lower
-
Pre-Open Winners 6/21: (ONXX) (SUNH) (EGLE) Higher (more...)
Back to LGND Stock Lookup
